Related Experiment Video
Updated: Aug 5, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
From Prototype to Clinical Workflow: Co-Developing a Wearable Hypomimia System for Parkinson's Disease
Alexander Johannes Wiederhold1, Lea Haidar1, Monika Pötter-Nerger2
1Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
Sensors (Basel, Switzerland)
|July 28, 2026
Summary
Researchers developed a wearable device to measure hypomimia, or reduced facial expressiveness, in Parkinson's disease (PD). The cap-mounted device showed improved usability and technical feasibility after patient-centered redesign, supporting its integration into routine clinical assessments.
Area of Science:
- Biomedical Engineering
- Neurology
- Human-Computer Interaction
Background:
- Hypomimia, characterized by reduced facial expressiveness, is a common symptom in Parkinson's disease (PD).
- Current clinical assessments of hypomimia, often using the MDS-UPDRS, are subjective and may not capture the full spectrum of the condition.
- There is a need for objective, reliable methods to quantify hypomimia in real-world clinical settings.
Purpose of the Study:
- To develop and refine a wearable, cap-mounted device for objective hypomimia recording.
- To assess the usability and technical feasibility of the device during routine inpatient Parkinson's disease assessments.
- To improve the device through iterative, patient-centered design based on clinical feedback.
Main Methods:
- A co-development process involving four prototypes and clinician workflow analysis.
- Evaluation of Prototype 3 using the System Usability Scale (SUS) and free-text feedback.
- Patient-centered redesign leading to Prototype 4, followed by bench testing and usability assessment with a larger cohort.
Main Results:
- Bench testing confirmed stable operation, robust housing, and reliable Wi-Fi data streaming.
- Usability significantly improved from moderate (SUS 44.7) in Prototype 3 to good (SUS 80.0) in Prototype 4.
- The device achieved a mean effective sampling rate of 4.79 frames/s with 95.4% face detection accuracy.
Conclusions:
- The iterative, patient-centered design process was crucial for enhancing device usability.
- Technical robustness and user-centered design are essential for the clinical validation of wearable assessment tools.
- The developed wearable hypomimia capture device shows promise for integration into routine Parkinson's disease assessments.
